Publications by authors named "Janet Gould"

Claim this Profile
C
Concern regarding "A novel decision tree for performing risk assessments of biologics in a health-system setting".
Melissa McDiarmid, Thomas Connor, Patricia Kienle, Jerry Ovesen, Janet Gould

J Oncol Pharm Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantum-Mechanics Calculations Elucidate Skin-Sensitizing Pharmaceutical Compounds.
Jakub Kostal, Adelina Voutchkova-Kostal, Joel P Bercu, Jessica C Graham, Jedd Hillegass, Janet Gould

Chem Res Toxicol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
Jessica C Graham, Nathan Wilt, Gertrude-Emilia Costin, Caren Villano, Jackie Bader, Janet Gould

Cutan Ocul Toxicol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations.
Janet C Gould, Irvith Carvajal, Todd Davidson, Jessica Graham, Jedd Hillegass

Regul Toxicol Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation of Permitted Daily Exposure for Flutamide.
Janet Gould, Edward V Sargent, Robert Sussman

Toxicol Sci· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert-derived structure-activity alert spaces.
Steven J Canipa, Martyn L Chilton, Rachel Hemingway, Donna S Macmillan, Alun Myden, Janet Gould

J Appl Toxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Special endpoint and product specific considerations in pharmaceutical acceptable daily exposure derivation.
Janet Gould, Courtney M Callis, David G Dolan, Brad Stanard, Patricia A Weideman

Regul Toxicol Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioavailability of therapeutic proteins by inhalation--worker safety aspects.
Thomas Pfister, David Dolan, Joel Bercu, Janet Gould, Bonnie Wang

Ann Occup Hyg· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of low-dose clinical pharmacodynamic and pharmacokinetic data to establish an occupational exposure limit for dapagliflozin, a potent inhibitor of the renal sodium glucose co-transporter 2.
Janet C Gould, Sreeneeranj Kasichayanula, David C Shepperly, David W Boulton

Regul Toxicol Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hazard identification of strong dermal sensitizers.
Janet C Gould, Stephan Taylor

Toxicol Mech Methods· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis